Artwork

Inhoud geleverd door Cancer Research UK. Alle podcastinhoud, inclusief afleveringen, afbeeldingen en podcastbeschrijvingen, wordt rechtstreeks geüpload en geleverd door Cancer Research UK of hun podcastplatformpartner. Als u denkt dat iemand uw auteursrechtelijk beschermde werk zonder uw toestemming gebruikt, kunt u het hier beschreven proces https://nl.player.fm/legal volgen.
Player FM - Podcast-app
Ga offline met de app Player FM !

Can we grow the treatments of tomorrow?

32:36
 
Delen
 

Manage episode 301342901 series 18171
Inhoud geleverd door Cancer Research UK. Alle podcastinhoud, inclusief afleveringen, afbeeldingen en podcastbeschrijvingen, wordt rechtstreeks geüpload en geleverd door Cancer Research UK of hun podcastplatformpartner. Als u denkt dat iemand uw auteursrechtelijk beschermde werk zonder uw toestemming gebruikt, kunt u het hier beschreven proces https://nl.player.fm/legal volgen.

From malaria to multiple sclerosis, plants have given us compounds which help treat countless conditions. But could a tree growing on your street hold the next life-changing drug?


From Madagascar to a Kew Gardens in London, we explore how scientists across the globe use indigenous knowledge and pharmaceutical science to help develop the treatments of tomorrow.


And in a world-first, a cannabis-derived drug, known as Sativex, is being trialled in combination with chemotherapy to see if it could be used to help people with a certain type of aggressive brain cancer.

  • The botanical history of medicine (2:04)
  • How do we find the plant medicines of tomorrow? (6:10)
  • The search for a chemical needle in a botanical haystack (9:09)
  • Making drugs: converting cuttings into capsules (14:02)
  • Is it more complex than putting a leaf in a pill? (18:28)
  • Sativex: trialling a cannabis-derived spray on brain cancer (22:50)
  • Do we know how cannabinoids work on brain tumour cells? (26:51)
  • Cannabis and cancer: it's not that simple (28:43)

ARISTOCRAT is a randomised phase II study of temozolomide with or without cannabinoids in patients with recurrent glioblastoma.


It's being funded by The Brain Tumour Charity and co-ordinated by the Cancer Research UK Clinical Trials Unit at the University of Birmingham.


ARISTOCRAT is due to begin recruiting just over 230 patients across all UK nations in early 2022.


To learn more about the ARISTOCRAT trial, you can check out:

If you’d like to talk to someone, our nurses are available Monday to Friday 9-5pm on freephone 0808 800 4040.



Hosted on Acast. See acast.com/privacy for more information.

  continue reading

17 afleveringen

Artwork
iconDelen
 
Manage episode 301342901 series 18171
Inhoud geleverd door Cancer Research UK. Alle podcastinhoud, inclusief afleveringen, afbeeldingen en podcastbeschrijvingen, wordt rechtstreeks geüpload en geleverd door Cancer Research UK of hun podcastplatformpartner. Als u denkt dat iemand uw auteursrechtelijk beschermde werk zonder uw toestemming gebruikt, kunt u het hier beschreven proces https://nl.player.fm/legal volgen.

From malaria to multiple sclerosis, plants have given us compounds which help treat countless conditions. But could a tree growing on your street hold the next life-changing drug?


From Madagascar to a Kew Gardens in London, we explore how scientists across the globe use indigenous knowledge and pharmaceutical science to help develop the treatments of tomorrow.


And in a world-first, a cannabis-derived drug, known as Sativex, is being trialled in combination with chemotherapy to see if it could be used to help people with a certain type of aggressive brain cancer.

  • The botanical history of medicine (2:04)
  • How do we find the plant medicines of tomorrow? (6:10)
  • The search for a chemical needle in a botanical haystack (9:09)
  • Making drugs: converting cuttings into capsules (14:02)
  • Is it more complex than putting a leaf in a pill? (18:28)
  • Sativex: trialling a cannabis-derived spray on brain cancer (22:50)
  • Do we know how cannabinoids work on brain tumour cells? (26:51)
  • Cannabis and cancer: it's not that simple (28:43)

ARISTOCRAT is a randomised phase II study of temozolomide with or without cannabinoids in patients with recurrent glioblastoma.


It's being funded by The Brain Tumour Charity and co-ordinated by the Cancer Research UK Clinical Trials Unit at the University of Birmingham.


ARISTOCRAT is due to begin recruiting just over 230 patients across all UK nations in early 2022.


To learn more about the ARISTOCRAT trial, you can check out:

If you’d like to talk to someone, our nurses are available Monday to Friday 9-5pm on freephone 0808 800 4040.



Hosted on Acast. See acast.com/privacy for more information.

  continue reading

17 afleveringen

Alle afleveringen

×
 
Loading …

Welkom op Player FM!

Player FM scant het web op podcasts van hoge kwaliteit waarvan u nu kunt genieten. Het is de beste podcast-app en werkt op Android, iPhone en internet. Aanmelden om abonnementen op verschillende apparaten te synchroniseren.

 

Korte handleiding